Covered recipient · General Payments record
MANISHA S PARIKH
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$3,933.58
- Reported across 192 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $631.34 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $202.84 | 12 |
| SHIELD THERAPEUTICS INC | $97.65 | 2 |
| Astellas Pharma US Inc | $81.92 | 5 |
| Organon LLC | $50.90 | 2 |
| Exeltis, USA Inc. | $46.33 | 3 |
| Novo Nordisk AS | $38.33 | 2 |
| MILLICENT US INC | $35.54 | 2 |
| PFIZER INC. | $26.18 | 1 |
| Hologic Sales and Service, LLC | $19.84 | 1 |
| Exact Sciences Corporation | $17.27 | 1 |
| Agile Therapeutics, Inc. | $14.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Agile Therapeutics, Inc. | $14.54 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154841344 | CMS |
| Astellas Pharma US Inc | $15.98 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139290768 | CMS |
| Astellas Pharma US Inc | $19.65 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139295394 | CMS |
| Astellas Pharma US Inc | $15.12 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139354319 | CMS |
| Astellas Pharma US Inc | $15.54 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139280980 | CMS |
| Astellas Pharma US Inc | $15.63 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139415147 | CMS |
| Biogen, Inc. | $21.70 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104852548 | CMS |
| Biogen, Inc. | $5.51 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104812907 | CMS |
| Biogen, Inc. | $1.69 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104852944 | CMS |
| Biogen, Inc. | $17.63 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104831666 | CMS |
| Biogen, Inc. | $22.42 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104846844 | CMS |
| Biogen, Inc. | $16.33 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104812547 | CMS |
| Biogen, Inc. | $23.28 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104808127 | CMS |
| Biogen, Inc. | $22.67 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104832760 | CMS |
| Biogen, Inc. | $17.61 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104829460 | CMS |
| Biogen, Inc. | $17.01 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104875406 | CMS |
| Biogen, Inc. | $16.56 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104864106 | CMS |
| Biogen, Inc. | $20.43 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104846846 | CMS |
| Exact Sciences Corporation | $17.27 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114822721 | CMS |
| Exeltis, USA Inc. | $16.24 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150001398 | CMS |
| Exeltis, USA Inc. | $15.50 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150001400 | CMS |
| Exeltis, USA Inc. | $14.59 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150001402 | CMS |
| Hologic Sales and Service, LLC | $19.84 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084914984 | CMS |
| MILLICENT US INC | $18.74 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150910672 | CMS |
| MILLICENT US INC | $16.80 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150910674 | CMS |
| Novo Nordisk Inc | $18.49 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097512572 | CMS |
| Novo Nordisk Inc | $19.84 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097246452 | CMS |
| Organon Llc | $20.01 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238917 | CMS |
| Organon Llc | $30.89 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238913 | CMS |
| PFIZER INC. | $26.18 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131360157 | CMS |
| SHIELD THERAPEUTICS INC | $20.97 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150129036 | CMS |
| SHIELD THERAPEUTICS INC | $76.68 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150136025 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.